Skip to main content

Table 1 Patient, tumor and treatment characteristics of the study

From: Actual long-term survival after resection of stage III soft tissue sarcoma

  Long-term survivors (n = 61) Short-term survivors (n = 36) P-value
Patient characteristics
 Age (years) 48 (13–82) 59.5 (19–83) n.s.
 Sex (male) 32 (52.5%) 22 (61.1%) n.s.
 ASA score    0.006
  I 38 (62.3%) 11 (30.6%)  
  II 21 (34.4%) 23 (63.9%)  
  III 2 (3.3%) 2 (5.6%)  
Tumor characteristics
 Location (extremity) 50 (82.0%) 28 (77.8%) n.s.
 Initial presentation
  Unplanned excision 5 (8.2%) 1 (2.8%) n.s.
 Size
  > 10 cm 22 (36.1%) 21 (58.3%) 0.037
 FNCLCC Grade
  3 29 (47.5%) 26 (72.2%) 0.021
 Depth
  Superficial 5 (8.2%) 1 (2.8%) n.s.
 Histological subtypes
  Leiomyosarcoma 3 (4.9%) 7 (19.4%) 0.036
Treatment characteristics
 Surgical
  Marginal 9 (14.8%) 9 (25%) n.s.
 Microscopic margin
  R1 3 (4.9%) 6 (16.7%) 0.024
 Administration of adjuvant chemotherapy 18 (29.5%) 13 (36.1%) n.s.
Administration of adjuvant radiotherapy 55 (90.2%) 21 (58.3%) 0.001
  1. n.s. Not significant, ASA American Society of Anesthesiologists, FNCLCC Fédération Nationale des Centres de Lutte Contre le Cancer, R1 Microscopically positive surgical margin